DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Schreiber S, Rutgeerts P, Fedorak RN et al.
A randomized, placebo-controlled trial of certolizumab pegol (CDP870) for treatment of Crohn’s disease.
Gastroenterology 2005;
129: 807-817
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.